Please Wait.....
Report
Remote Patient Monitoring (RPM) - Company Evaluation Report, 2024
Market Report I 2025-08-01 I 179 Pages I MarketsandMarkets
The Remote Patient Monitoring (RPM) Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Remote Patient Monitoring (RPM). This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 100 companies, of which the Top 21 Remote Patient Monitoring (RPM) Companies were categorized and recognized as quadrant leaders.
This report categorizes the market based on component, indication, end user, and region. Telehealth and remote patient monitoring (RPM) technologies contribute to cost reduction by enhancing healthcare efficiency and alleviating the workload of hospitals and medical personnel. Moreover, these technologies allow patients to receive ongoing care at home, which leads to improved health outcomes and more effective care delivery. However, differences in regulatory frameworks across regions may pose challenges to market growth, requiring careful navigation to support broader adoption of these technologies.
The remote patient monitoring (RPM) market encompasses the use of technology to track and manage patients' health conditions remotely, both outside traditional healthcare facilities and within patient settings. It utilizes devices such as wearables, sensors, and mobile apps to monitor vital signs and chronic conditions. RPM provides healthcare professionals with real-time data, enabling more informed decisions and tailored patient care.
The 360 Quadrant maps the Remote Patient Monitoring (RPM) companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the Remote Patient Monitoring (RPM) quadrant. The top criteria for product footprint evaluation included.
Key players in the Remote Patient Monitoring (RPM) market include major global corporations and specialized innovators such as Koninklijke Philips N.V., Omron Healthcare, Inc. (Subsidiary of Omron Corporation), Medtronic, GE Healthcare, Abbott, Oracle, Boston Scientific Corporation, Nihon Kohden Corporation, Siemens Healthineers AG, Baxter, Biobeat, Biotronik, Vitalconnect, Vivalnk, Inc., Cleararch, Inc., Optum, Inc. (Vivify Health, Part of Optum), Blue Spark Technologies, Inc., Lightbeam, Cloud Diagnostics Canada ULC, Teladoc Health, Inc., and Guangdong Transtek Medical Electronics Co., Ltd.. These companies are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.
Top 3 Companies
Koninklijke Philips N.V.
Koninklijke Philips N.V. is a leader in the RPM market through its innovative products in healthcare and consumer lifestyle sectors. Under its Connected Care segment, Philips offers advanced patient monitoring systems that utilize real-time data to improve clinical workflows and reduce hospital readmissions. Philips's diversified technology benefits both its consumer and medical business arms, making it a dominant player globally.
Medtronic
Medtronic is renowned for its broad portfolio in the medical devices arena, leading in revenue across several fiscal years. The company continually invests in RPM innovations to track patient health metrics effectively. Medtronic's strategic growth is marked by collaborations and acquisitions, reinforcing its market leadership and enabling it to harness new opportunities across emerging markets.
Abbott
Abbott Laboratories excels in remote patient monitoring via its Diagnostic Products and Medical Devices segments, focusing on chronic disease management with advanced monitoring devices. Abbott's global operations, particularly through subsidiaries, ensure a vast market reach and robust distribution network. Its continuous innovation in healthcare solutions underpins its influential status in the RPM market.
1 INTRODUCTION 15
1.1 MARKET DEFINITION 15
1.2 INCLUSIONS & EXCLUSIONS 15
1.3 STAKEHOLDERS 16
2 EXECUTIVE SUMMARY 17
3 MARKET OVERVIEW 21
3.1 INTRODUCTION 21
3.1.1 DRIVERS 23
3.1.1.1 Transformation of patient care through digital innovation 23
3.1.1.2 Expansion of telehealth in remote patient monitoring 25
3.1.1.3 Rising prevalence of chronic diseases 25
3.1.1.4 Increasing geriatric population and rising uptake of RPM services 26
3.1.1.5 Growing need for cost-containment across healthcare facilities 27
3.1.1.6 Technological innovation in wearables, mhealth apps,
and connected devices 28
3.1.2 RESTRAINTS 29
3.1.2.1 High investments and lack of IT expertise 29
3.1.2.2 Behavioral barriers and healthcare affordability challenges in
remote patient monitoring 29
3.1.2.3 Challenges associated with 2024 CMS regulations 29
3.1.3 OPPORTUNITIES 30
3.1.3.1 Emergence of AI & ML 30
3.1.3.2 Gradual shift toward outpatient care environments 31
3.1.3.3 Increasing utilization for infectious disease diagnostics 32
3.1.3.4 Rising initiatives for hospital-at-home programs 32
3.1.4 CHALLENGES 33
3.1.4.1 Concerns associated with data security 33
3.1.4.2 Data accessibility issues 35
3.1.4.3 incorporation of SDOH factors into RPM programs 36
3.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 36
3.2.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET 36
3.3 INDUSTRY TRENDS 37
3.3.1 GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE 37
3.4 ECOSYSTEM ANALYSIS 37
3.5 VALUE CHAIN ANALYSIS 39
3.6 TECHNOLOGY ANALYSIS 40
3.6.1 KEY TECHNOLOGIES 40
3.6.1.1 Miniature wearable devices 40
3.6.1.2 Artificial intelligence & machine learning 41
3.6.1.3 Cloud computing 41
3.6.1.4 Patient engagement tools 41
3.6.1.5 EHR integration 41
3.6.1.6 Voice assistant integration 42
3.6.2 COMPLEMENTARY TECHNOLOGIES 42
3.6.2.1 5G connectivity 42
3.6.2.2 mHealth apps 42
3.6.2.3 Digital therapeutics 42
3.6.2.4 Telehealth platforms 43
3.6.3 ADJACENT TECHNOLOGIES 43
3.6.3.1 POC diagnostics 43
3.6.3.2 Smart home health devices 43
3.7 PORTER'S FIVE FORCES ANALYSIS 44
3.7.1 THREAT OF NEW ENTRANTS 45
3.7.2 THREAT OF SUBSTITUTES 45
3.7.3 BARGAINING POWER OF MANUFACTURERS 46
3.7.4 BARGAINING POWER OF BUYERS 46
3.7.5 INTENSITY OF COMPETITIVE RIVALRY 46
3.8 PATENT ANALYSIS 46
3.8.1 PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING 46
3.8.2 JURISDICTION AND TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING 47
3.8.3 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET 49
3.9 KEY CONFERENCES AND EVENTS, 2025?2026 50
3.9.1 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025?2026 50
3.10 REMOTE PATIENT MONITORING BUSINESS MODEL 51
3.10.1 SUBSCRIPTION-BASED MODELS 51
3.10.2 PLATFORM AS A SERVICE (PAAS) 51
3.10.3 FREEMIUM MODELS WITH PREMIUM FEATURES 51
3.10.4 COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS 51
3.11 IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET 52
3.11.1 KEY USE CASES 53
3.11.2 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 54
3.11.2.1 Telehealth & telemedicine 55
3.11.2.2 Wearable devices 55
3.11.2.3 Digital healthcare 55
3.11.2.4 Home healthcare 55
3.11.3 USER READINESS & IMPACT ASSESSMENT 56
3.11.3.1 User readiness 56
3.11.3.1.1 User A: Hospitals 56
3.11.3.1.2 User B: Ambulatory surgery centers 56
3.11.3.2 Impact assessment 56
3.11.3.2.1 User A: Hospitals 56
3.11.3.2.1.1 Implementation 56
3.11.3.2.1.2 Impact 57
3.11.3.2.2 User B: Ambulatory surgery centers 57
3.11.3.2.2.1 Implementation 57
3.11.3.2.2.2 Impact 57
4 COMPETITIVE LANDSCAPE 58
4.1 OVERVIEW 58
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 58
4.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
REMOTE PATIENT MONITORING MARKET 58
4.3 REVENUE ANALYSIS, 2019-2023 63
4.4 MARKET SHARE ANALYSIS, 2023 64
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 67
4.5.1 STARS 67
4.5.2 EMERGING LEADERS 67
4.5.3 PERVASIVE PLAYERS 68
4.5.4 PARTICIPANTS 68
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 69
4.5.5.1 Company footprint 69
4.5.5.2 Region footprint 70
4.5.5.3 Component footprint 71
4.5.5.4 Indication footprint 72
4.5.5.5 End-user footprint 73
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 74
4.6.1 PROGRESSIVE COMPANIES 74
4.6.2 RESPONSIVE COMPANIES 74
4.6.3 DYNAMIC COMPANIES 74
4.6.4 STARTING BLOCKS 74
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 76
4.6.5.1 Detailed list of key startups/SMEs 76
4.6.5.2 Competitive benchmarking of startups/SMEs 76
4.7 COMPANY VALUATION & FINANCIAL METRICS 77
4.7.1 FINANCIAL METRICS 77
4.7.2 COMPANY VALUATION 77
4.8 BRAND/SOFTWARE COMPARISON 78
4.9 COMPETITIVE SCENARIO 79
4.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 79
4.9.2 DEALS 81
4.9.3 EXPANSIONS 84
4.9.4 OTHER DEVELOPMENTS 84
5 COMPANY PROFILES 85
5.1 KEY PLAYERS 85
5.1.1 KONINKLIJKE PHILIPS N.V. 85
5.1.1.1 Business overview 85
5.1.1.2 Products/Services offered 86
5.1.1.3 Recent developments 90
5.1.1.3.1 Product/Service launches & approvals 90
5.1.1.3.2 Deals 91
5.1.1.4 MnM view 92
5.1.1.4.1 Key strengths 92
5.1.1.4.2 Strategic choices 92
5.1.1.4.3 Weaknesses & competitive threats 92
5.1.2 OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION) 93
5.1.2.1 Business overview 93
5.1.2.2 Products/Services offered 94
5.1.2.3 Recent developments 96
5.1.2.3.1 Product/Service launches 96
5.1.2.3.2 Deals 97
5.1.2.3.3 Other developments 97
5.1.2.4 MnM view 98
5.1.2.4.1 Key strengths 98
5.1.2.4.2 Strategic choices 98
5.1.2.4.3 Weaknesses & competitive threats 98
5.1.3 MEDTRONIC 99
5.1.3.1 Business overview 99
5.1.3.2 Products/Services offered 100
5.1.3.3 Recent developments 102
5.1.3.3.1 Product/Service approvals 102
5.1.3.3.2 Deals 103
5.1.3.4 MnM view 104
5.1.3.4.1 Key strengths 104
5.1.3.4.2 Strategic choices 104
5.1.3.4.3 Weaknesses & competitive threats 104
5.1.4 GE HEALTHCARE 105
5.1.4.1 Business overview 105
5.1.4.2 Products/Services offered 106
5.1.4.3 Recent developments 108
5.1.4.3.1 Product/Service launches & approvals 108
5.1.4.3.2 Deals 108
5.1.4.4 MnM view 109
5.1.4.4.1 Key strengths 109
5.1.4.4.2 Strategic choices 109
5.1.4.4.3 Weaknesses & competitive threats 109
5.1.5 ABBOTT 110
5.1.5.1 Business overview 110
5.1.5.2 Products/Services offered 111
5.1.5.3 Recent developments 112
5.1.5.3.1 Product/Service launches 112
5.1.5.3.2 Deals 113
5.1.5.3.3 Expansions 114
5.1.5.4 MnM view 114
5.1.5.4.1 Key strengths 114
5.1.5.4.2 Strategic choices 114
5.1.5.4.3 Weaknesses & competitive threats 114
5.1.6 ORACLE 115
5.1.6.1 Business overview 115
5.1.6.2 Products/Services offered 116
5.1.6.3 Recent developments 117
5.1.6.3.1 Deals 117
5.1.7 BOSTON SCIENTIFIC CORPORATION 118
5.1.7.1 Business overview 118
5.1.7.2 Products/Services offered 119
5.1.7.3 Recent developments 120
5.1.7.3.1 Product/Service launches & enhancements 120
5.1.7.3.2 Deals 121
5.1.7.3.3 Expansions 121
5.1.8 NIHON KOHDEN CORPORATION 122
5.1.8.1 Business overview 122
5.1.8.2 Products/Services offered 124
5.1.8.3 Recent developments 125
5.1.8.3.1 Product/Service launches 125
5.1.8.3.2 Deals 125
5.1.8.3.3 Expansions 126
5.1.9 SIEMENS HEALTHINEERS AG 127
5.1.9.1 Business overview 127
5.1.9.2 Products/Services offered 128
5.1.9.3 Recent developments 129
5.1.9.3.1 Product/Service launches & approvals 129
5.1.9.3.2 Deals 130
5.1.10 BAXTER 131
5.1.10.1 Business overview 131
5.1.10.2 Products/Services offered 132
5.1.10.3 Recent developments 133
5.1.10.3.1 Product/Service launches & approvals 133
5.1.10.3.2 Deals 133
5.1.11 BIOBEAT 134
5.1.11.1 Business overview 134
5.1.11.2 Products/Services offered 134
5.1.11.3 Recent developments 135
5.1.11.3.1 Product/Service launches & approvals 135
5.1.11.3.2 Deals 136
5.1.12 BIOTRONIK 138
5.1.12.1 Business overview 138
5.1.12.2 Products/Services offered 138
5.1.12.3 Recent developments 139
5.1.12.3.1 Product/Service launches & approvals 139
5.1.12.3.2 Deals 140
5.1.13 VITALCONNECT 141
5.1.13.1 Business overview 141
5.1.13.2 Products/Services offered 141
5.1.13.3 Recent developments 142
5.1.13.3.1 Product/Service launches 142
5.1.13.3.2 Deals 142
5.1.13.3.3 Other developments 142
5.1.14 VIVALNK, INC. 143
5.1.14.1 Business overview 143
5.1.14.2 Products/Services offered 143
5.1.14.3 Recent developments 144
5.1.14.3.1 Product/Service launches & enhancements 144
5.1.14.3.2 Deals 145
5.1.15 CLEARARCH, INC. 146
5.1.15.1 Business overview 146
5.1.15.2 Products/Services offered 146
5.1.15.3 Recent developments 147
5.1.15.3.1 Product/Service launches 147
5.1.15.3.2 Deals 148
5.1.16 OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM) 149
5.1.16.1 Business overview 149
5.1.16.2 Products/Services offered 150
5.1.17 BLUE SPARK TECHNOLOGIES, INC. 151
5.1.17.1 Business overview 151
5.1.17.2 Products/Services offered 151
5.1.17.3 Recent developments 152
5.1.17.3.1 Product/Service launches 152
5.1.17.3.2 Deals 152
5.1.17.3.3 Other developments 153
5.1.18 LIGHTBEAM 154
5.1.18.1 Business overview 154
5.1.18.2 Products/Services offered 154
5.1.18.3 Recent developments 155
5.1.18.3.1 Deals 155
5.1.19 CLOUD DIAGNOSTICS CANADA ULC 156
5.1.19.1 Business overview 156
5.1.19.2 Products/Services offered 156
5.1.19.3 Recent developments 157
5.1.19.3.1 Product/Service launches 157
5.1.19.3.2 Deals 157
5.1.20 TELADOC HEALTH, INC. 159
5.1.20.1 Business overview 159
5.1.20.2 Products/Services offered 161
5.1.20.3 Recent developments 161
5.1.20.3.1 Product/Service launches 161
5.1.20.3.2 Deals 162
5.1.21 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD. 163
5.1.21.1 Business overview 163
5.1.21.2 Products/Services offered 164
5.1.21.3 Recent developments 165
5.1.21.3.1 Product/Service launches 165
5.2 OTHER PLAYERS 166
5.2.1 CARESIMPLE INC. 166
5.2.2 TIMEDOC, INC. 167
5.2.3 MD REVOLUTION INC. 168
5.2.4 OPTIMIZE HEALTH, INC. 169
5.2.5 HEALTH RECOVERY SOLUTIONS 170
6 APPENDIX 171
6.1 RESEARCH METHODOLOGY 171
6.1.1 RESEARCH DATA 171
6.1.1.1 Secondary data 172
6.1.1.2 Primary data 173
6.1.2 RESEARCH ASSUMPTIONS 174
6.1.3 RISK ASSESSMENT 175
6.1.4 RESEARCH LIMITATIONS 176
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 176
6.3 AUTHOR DETAILS 179
TABLE 1 REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS 22
TABLE 2 RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022-DECEMBER 2024 31
TABLE 3 TOP 5 HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES 35
TABLE 4 REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS 45
TABLE 5 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR
REMOTE PATIENT MONITORING 48
TABLE 6 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021-JANUARY 2025 58
TABLE 7 REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION 65
TABLE 8 REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT 70
TABLE 9 REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT 71
TABLE 10 REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT 72
TABLE 11 REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 73
TABLE 12 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS 76
TABLE 13 REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING OF
KEY EMERGING PLAYERS/STARTUPS, BY REGION 76
TABLE 14 REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-JANUARY 2025 79
TABLE 15 REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021-JANUARY 2025 81
TABLE 16 REMOTE PATIENT MONITORING MARKET:
EXPANSIONS, JANUARY 2021-JANUARY 2025 84
TABLE 17 REMOTE PATIENT MONITORING MARKET:
OTHER DEVELOPMENTS, JANUARY 2021-JANUARY 2025 84
TABLE 18 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 85
TABLE 19 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 86
TABLE 20 KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021?JANUARY 2025 90
TABLE 21 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021?JANUARY 2025 91
TABLE 22 OMRON CORPORATION: COMPANY OVERVIEW 93
TABLE 23 OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED 94
TABLE 24 OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021?JANUARY 2025 96
TABLE 25 OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021?JANUARY 2025 97
TABLE 26 OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS,
JANUARY 2021?JANUARY 2025 97
TABLE 27 MEDTRONIC: COMPANY OVERVIEW 99
TABLE 28 MEDTRONIC: PRODUCTS/SERVICES OFFERED 100
TABLE 29 MEDTRONIC: PRODUCT/SERVICE APPROVALS, JANUARY 2021?JANUARY 2025 102
TABLE 30 MEDTRONIC: DEALS, JANUARY 2021?JANUARY 2025 103
TABLE 31 GE HEALTHCARE: COMPANY OVERVIEW 105
TABLE 32 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 106
TABLE 33 GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021?JANUARY 2025 108
TABLE 34 GE HEALTHCARE: DEALS, JANUARY 2021?JANUARY 2025 108
TABLE 35 ABBOTT: COMPANY OVERVIEW 110
TABLE 36 ABBOTT: PRODUCTS/SERVICES OFFERED 111
TABLE 37 ABBOTT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021?JANUARY 2025 112
TABLE 38 ABBOTT: DEALS, JANUARY 2021?JANUARY 2025 113
TABLE 39 ABBOTT: EXPANSIONS, JANUARY 2021?JANUARY 2025 114
TABLE 40 ORACLE: COMPANY OVERVIEW 115
TABLE 41 ORACLE: PRODUCTS/SERVICES OFFERED 116
TABLE 42 ORACLE: DEALS, JANUARY 2021?JANUARY 2025 117
TABLE 43 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 118
TABLE 44 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED 119
TABLE 45 BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021?JANUARY 2025 120
TABLE 46 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021?JANUARY 2025 121
TABLE 47 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021?JANUARY 2025 121
TABLE 48 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 122
TABLE 49 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED 124
TABLE 50 NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021?JANUARY 2025 125
TABLE 51 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021?JANUARY 2025 125
TABLE 52 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021?JANUARY 2025 126
TABLE 53 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 127
TABLE 54 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 128
TABLE 55 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021?JANUARY 2025 129
TABLE 56 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021?JANUARY 2025 130
TABLE 57 BAXTER: COMPANY OVERVIEW 131
TABLE 58 BAXTER: PRODUCTS/SERVICES OFFERED 132
TABLE 59 BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021?JANUARY 2025 133
TABLE 60 BAXTER: DEALS, JANUARY 2021?JANUARY 2025 133
TABLE 61 BIOBEAT: COMPANY OVERVIEW 134
TABLE 62 BIOBEAT: PRODUCTS/SERVICES OFFERED 134
TABLE 63 BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021?JANUARY 2025 135
TABLE 64 BIOBEAT: DEALS, JANUARY 2021?JANUARY 2025 136
TABLE 65 BIOTRONIK: COMPANY OVERVIEW 138
TABLE 66 BIOTRONIK: PRODUCTS/SERVICES OFFERED 138
TABLE 67 BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS,
JANUARY 2021?JANUARY 2025 139
TABLE 68 BIOTRONIK: DEALS, JANUARY 2021?JANUARY 2025 140
TABLE 69 VITALCONNECT: COMPANY OVERVIEW 141
TABLE 70 VITALCONNECT: PRODUCTS/SERVICES OFFERED 141
TABLE 71 VITALCONNECT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021?JANUARY 2025 142
TABLE 72 VITALCONNECT: DEALS, JANUARY 2021?JANUARY 2025 142
TABLE 73 VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2021?JANUARY 2025 142
TABLE 74 VIVALNK, INC.: COMPANY OVERVIEW 143
TABLE 75 VIVALNK, INC.: PRODUCTS/SERVICES OFFERED 143
TABLE 76 VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS,
JANUARY 2021?JANUARY 2025 144
TABLE 77 VIVALNK, INC.: DEALS, JANUARY 2021?JANUARY 2025 145
TABLE 78 CLEARARCH, INC.: COMPANY OVERVIEW 146
TABLE 79 CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED 146
TABLE 80 CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021?JANUARY 2025 147
TABLE 81 CLEARARCH, INC.: DEALS, JANUARY 2021?JANUARY 2025 148
TABLE 82 OPTUM, INC.: COMPANY OVERVIEW 149
TABLE 83 OPTUM, INC.: PRODUCTS/SERVICES OFFERED 150
TABLE 84 BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW 151
TABLE 85 BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 151
TABLE 86 BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021?JANUARY 2025 152
TABLE 87 BLUE SPARK TECHNOLOGIES, INC.: DEALS, JANUARY 2021?JANUARY 2025 152
TABLE 88 BLUE SPARK TECHNOLOGIES, INC.: OTHER DEVELOPMENTS,
JANUARY 2021?JANUARY 2025 153
TABLE 89 LIGHTBEAM: COMPANY OVERVIEW 154
TABLE 90 LIGHTBEAM: PRODUCTS/SERVICES OFFERED 154
TABLE 91 LIGHTBEAM: DEALS, JANUARY 2021?JANUARY 2025 155
TABLE 92 CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW 156
TABLE 93 CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED 156
TABLE 94 CLOUD DIAGNOSTICS CANADA ULC: PRODUCT LAUNCHES,
JANUARY 2021?JANUARY 2025 157
TABLE 95 CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2021?JANUARY 2025 157
TABLE 96 TELADOC HEALTH, INC.: COMPANY OVERVIEW 159
TABLE 97 TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED 161
TABLE 98 TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021?JANUARY 2025 161
TABLE 99 TELADOC HEALTH, INC.: DEALS, JANUARY 2021?JANUARY 2025 162
TABLE 100 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 163
TABLE 101 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.:
PRODUCTS/SERVICES OFFERED 164
TABLE 102 GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: P
RODUCT/SERVICE LAUNCHES, JANUARY 2021?JANUARY 2025 165
TABLE 103 MARKET SIZING ASSUMPTIONS 174
TABLE 104 RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET 175
FIGURE 1 REMOTE PATIENT MONITORING MARKET, BY COMPONENT,
2024 VS. 2030 (USD MILLION) 17
FIGURE 2 REMOTE PATIENT MONITORING MARKET, BY INDICATION,
2024 VS. 2030 (USD MILLION) 18
FIGURE 3 REMOTE PATIENT MONITORING MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 19
FIGURE 4 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT 20
FIGURE 5 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 22
FIGURE 6 DIGITAL HEALTH FUNDING HISTORY, 2020?2024 (USD BILLION) 24
FIGURE 7 NUMBER OF DEALS IN DIGITAL HEALTH (2020?2024) 24
FIGURE 8 US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024) 32
FIGURE 9 HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009-2024 33
FIGURE 10 HEALTHCARE SECURITY BREACHES, 2009-2023 34
FIGURE 11 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS 38
FIGURE 12 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS 40
FIGURE 13 REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS 44
FIGURE 14 GLOBAL PATENT PUBLICATION TRENDS IN REMOTE PATIENT MONITORING MARKET, 2015-2024 47
FIGURE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE
PATIENT MONITORING PATENTS (JANUARY 2015-NOVEMBER 2024) 47
FIGURE 16 LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET
(JANUARY 2015-NOVEMBER 2024) 49
FIGURE 17 POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING
ACROSS INDUSTRIES 53
FIGURE 18 REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2019-2023 (USD MILLION) 63
FIGURE 19 MARKET SHARE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET (2023) 65
FIGURE 20 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 68
FIGURE 21 REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT 69
FIGURE 22 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 75
FIGURE 23 EV/EBITDA OF KEY VENDORS 77
FIGURE 24 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 77
FIGURE 25 REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE
COMPARATIVE ANALYSIS 78
FIGURE 26 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 86
FIGURE 27 OMRON CORPORATION: COMPANY SNAPSHOT (2023) 94
FIGURE 28 MEDTRONIC: COMPANY SNAPSHOT (2023) 100
FIGURE 29 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 106
FIGURE 30 ABBOTT: COMPANY SNAPSHOT (2023) 111
FIGURE 31 ORACLE: COMPANY SNAPSHOT (2023) 116
FIGURE 32 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 119
FIGURE 33 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 123
FIGURE 34 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 128
FIGURE 35 BAXTER: COMPANY SNAPSHOT (2023) 132
FIGURE 36 TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2023) 160
FIGURE 37 RESEARCH DESIGN 171
FIGURE 38 PRIMARY SOURCES 173
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security